Frequency of Cardiovascular Complications in Coronavirus-19 infected Patients during the second wave in a tertiary care Hospital of Lahore, Pakistan: Cardiovascular Complications in COVID-19 patients

Ayesha  Tariq; Aneeza  Jamshed; Muhammad Saad  Shabbir; Muhammad Arsalan  Aslam; Ali  Sajjad; Wajeeha  Aslam; Amna Komal  Khan

doi:10.52229/pbmj.v4i1.51

Authors

Ayesha Tariq Cardiology Department, Mayo Hospital, Lahore, Pakistan
Aneeza Jamshed Cardiology Department, Mayo Hospital, Lahore, Pakistan
Muhammad Saad Shabbir Cardiology Department, Mayo Hospital, Lahore, Pakistan
Muhammad Arsalan Aslam Cardiology Department, Mayo Hospital, Lahore, Pakistan
Ali Sajjad Faisalabad Institute of Cardiology, Faisalabad, Pakistan
Wajeeha Aslam Cardiology Department, Mayo Hospital, Lahore, Pakistan
Amna Komal Khan Department of Biotechnology, Kinnaird College for Women University, Lahore, Pakistan

DOI:

https://doi.org/10.52229/pbmj.v4i1.51

Abstract

Coronavirus 2019 (COVID-19) affects the cardiorespiratory systems by causing inflammation of the circulatory systems, hence, causing more cardiac complications in COVID-19 patients Objective: To observe the frequency of cardiac complications in COVID-19 patients during the second wave Methods: 235 COVID-19 patients presenting with cardiac complication to the Cardiology Department of Mayo Hospital, Lahore during 6 month periods of second wave of COVID-19 were included. Data regarding the medical history, age, gender was taken and the observed cardiac complication were noted Results: There were 76.6% male patients and 23.4% female patients. 56.2 % patients were already hypertensive, 37.9% were diabetic, 18.3% had familial history of cardiac diseases. The cardiovascular manifestations observed were, myocardial infarction (57.82%), 7.3% had angina, 21.3% had acute coronary syndrome and 12.3% had non ST elevation myocardial infarction. Conclusions: Our study suggests that there is a prevalence of cardiovascular diseases in COVID-patients which is a major concern as they are at increased risk for severe infection.

References

World Health Organization, 2020. https://time.com/5791661/who-coronavirus-pandemic-declaration/

Bansal M (2020). Cardiovascular disease and COVID-19. Diabetes Metab Syndr.14(3):247-250. doi: 10.1016/j.dsx.2020.03.013.

Adu-Amankwaah J, Mprah R, Adekunle AO, Ndzie Noah ML, Adzika GK, Machuki JO, Sun H (2021). The cardiovascular aspect of COVID-19. Ann. Med.53(1):227-236. doi: 10.1080/07853890.2020.1861644.

Kunal S, Gupta K, Sharma SM, Pathak V, Mittal S, Tarke C (2020). Cardiovascular system and COVID-19: perspectives from a developing country. Monaldi Arch. Chest Dis.90(2). doi: 10.4081/monaldi.2020.1305. PMID: 32380802.#

Rocco IS, Gomes WJ, Viceconte M, Bolzan DW, Moreira RSL, Arena R, Guizilini S (2020). Cardiovascular involvement in COVID-19: not to be missed. Braz. J. Cardiovasc. Surg.35(4):530-538. doi: 10.21470/1678-9741-2020-0224.

Moccia F, Gerbino A, Lionetti V, Miragoli M, Munaron LM, Pagliaro P, Pasqua T, Penna C, Rocca C, Samaja M, Angelone T (2020). COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. Geroscience. 42(4):1021-1049. doi: 10.1007/s11357-020-00198-w.

Ganatra S, Dani SS, Shah S, Asnani A, Neilan TG, Lenihan D, et al., (2020). Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic. Trends Cardiovasc. Med.30(6):315-325. doi: 10.1016/j.tcm.2020.05.004.

Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al., (2020). COVID-19 and comorbidities: Deleterious impact on infected patients. J. Infect. Public Hlth.13(12):1833-1839. doi: 10.1016/j.jiph.2020.07.014.

Bienvenu LA, Noonan J, Wang X, Peter K (2020). Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc. Res.116(14):2197-2206. doi: 10.1093/cvr/cvaa284.

Gencer S, Lacy M, Atzler D, van der Vorst EPC, Döring Y, Weber C (2020). Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19. Thromb. Haemost.120(12):1629-1641. doi: 10.1055/s-0040-1718735

Chang WT, Toh HS, Liao CT, Yu WL (2020). Cardiac Involvement of COVID-19: A Comprehensive Review. Am. J. Med. Sci.361(1):14-22. doi: 10.1016/j.amjms.2020.10.002.

Siddiqi HK, Libby P, Ridker PM (2021). COVID-19 - A vascular disease.Trends Cardiovasc. Med.31(1):1-5. doi: 10.1016/j.tcm.2020.10.005.

Xiaoliang Yan, Jing L, Deng Y (2020). COVID-19 with Cardiovascular Disease: Can It Help Predict Prognosis? Heart Surg. Forum.23(6):E895-E896. doi: 10.1532/hsf.3301.

Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G (2021). Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat. Rev. Nephrol.17(1):46-64. doi: 10.1038/s41581-020-00357-4.

Stokes EK, Zambrano LD, Anderson KN, Marder EP, Raz KM, Felix SEB, et al., (2020) Coronavirus disease 2019 case surveillance—United States, January 22–May 30, 2020. Morbidity and Mortality Weekly Report. 69(24):759.

Chaudhry A, Ikram A, Baig MA, Salman M, Ghafoor T, Hussain Z, et al., (2020). Mortality Analysis of COVID-19 Confirmed cases in Pakistan. MedRxiv.

Alsaied T, Aboulhosn JA, Cotts TB, Daniels CJ, Etheridge SP, Feltes TF, et al., (2020). Coronavirus Disease 2019 (COVID‐19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease.J. Am. Heart Assoc.9(12):e017224.

Sabatino J, Ferrero P, Chessa M, Bianco F, Ciliberti P, Secinaro A, et al., (2020).COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey. J. Clin. Med. 9(6):1774.

Chen Y, Gong X, Wang L, Guo J. (2020). Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis. MedRxiv.

Wadhera Rishi K, Shen C, Gondi S, Chen S, Kazi Dhruv S, Yeh Robert W (2021). Cardiovascular Deaths During the COVID-19 Pandemic in the United States. J. Am.College Cardiol. 77(2):159-69.

Einstein Andrew J, Shaw Leslee J, Hirschfeld C, Williams Michelle C, Villines Todd C, Better N, et al., (2021). International Impact of COVID-19 on the Diagnosis of Heart Disease. J.Am. College Cardiol. 77(2):173-85.